The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node

Clinical Nuclear Medicine

Volumn 31, Issue 12, 2006, Pages 795-800

  Argon, Aziz Murat ^a   Duygun, Ulkem ^a   Acar, Ebru ^a   Daglioz, Gozde ^a   Yenjay, Levent ^a   Zekioglu, Ozman ^a   Kapkac, Murat ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Gamma probe detection; Intradermal injection; Periareolar injection; Sentinel lymph node biopsy

Indexed keywords

AMERSCAN HEPATATE II; ISOSULFAN BLUE; TECHNETIUM TIN COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST AREOLA; BREAST CANCER; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FROZEN SECTION; GAMMA SCINTIGRAPHY; HUMAN; INJECTION SITE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PARENCHYMA; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM COMPOUNDS; TIN COMPOUNDS;

EID: 33751207383     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000246855.80027.b7     Document Type: Article

References (30)

1. Petrek JA, Blackwood MM. Axillary dissection: current practice and technique. Curr Probl Surg. 1995;32:259-323.
2. Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet. 1992;339:1245-1248.
3. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-340.
4. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet. 1997;349:1864.
5. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-1822.
6. Linehan DC, Hill AD, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol. 1999;6:450-454.
7. Motomura K, Inaji H, Komoike Y, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol. 2001;76:95-99.
8. Amerscan Hepatate II Product Information. Amersham International; 1984.
9. Hermanek P, Hutter RVP, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86:2668-2673.
10. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer staging manual. Cancer. 2003;98:2740-2741.
11. Boxen I, McCready D, Ballinger JR. Sentinel node detection and definition may depend on the imaging agent and timing. Clin Nucl Med. 1999;24:390-394.
12. Sato K, Uematsu M, Saito T, et al. Sentinel lymph node identification for patients with breast cancer using large-size radiotracer particles: technetium-99m-labeled tin colloids produced excellent results. Breast J. 2001;7:388-391.
13. Gulec SA, Moffat FL, Carroll RG, et al. Gamma probe guided sentinel node biopsy in breast cancer. Q J Nucl Med. 1997;41:251-261.
14. Paganelli G, De Cicco C, Cremonesi M, et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med. 1998;42:49-53.
15. Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002;131:277-286.
16. Motomura K, Komoike Y, Hasegawa Y, et al. Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients. J Surg Oncol. 2003;82:91-96.
17. Leidenius MH, Leppanen EA, Krogerus LA, et al. The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer. Nucl Med Commun. 2004;25:233-238.
18. Pelosi E, Bello M, Giors M, et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med. 2004;45:220-225.
19. Giuliano AE. Mapping a pathway for axillary staging: a personal perspective on the current status of sentinel lymph node dissection for breast cancer. Arch Surg. 1999;134:195-199.
20. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
21. Cserni G, Amendoeira I, Apostolikas N, et al. Pathological workup of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer. 2003;39:1654-1667.
22. Cserni G. Evaluation of sentinel lymph nodes in breast cancer. Histopathology. 2005;46:697-702.
23. Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer. 1997;80:1188-1197.
24. Meijnen P, Peterse JL, Nieweg OE, et al. Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer. Ned Tijdschr Geneeskd. 2004;148:2428-2432.
25. Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272-277.
26. Haigh PI, Hansen NM, Qi K, et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel. World J Surg. 1997;21:270-274.
27. van Wessem KJ, Meijer WS. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients. Breast. 2004;13:290-296.
28. Krynyckyi BR, Kim CK, Goyenechea MR, et al. Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images. Radiographics. 2004;24:121-145.
29. Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg. 2000;191:479-489.
30. Babiera GV, Delpassand ES, Breslin TM, et al. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med. 2005;30:11-15.